You have accessJournal of UrologyBladder Cancer: Invasive V (PD59)1 Sep 2021PD59-12 THE EFFECT OF PRIOR PROSTATE CANCER TREATMENT ON PERIOPERATIVE AND PATHOLOGICAL OUTCOMES AFTER CYSTECTOMY Kassem Faraj, Weslyn Bunn, Victoria Edmonds, and Mark Tyson Kassem FarajKassem Faraj More articles by this author , Weslyn BunnWeslyn Bunn More articles by this author , Victoria EdmondsVictoria Edmonds More articles by this author , and Mark TysonMark Tyson More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000002096.12AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Many men who undergo cystectomy have previously been diagnosed and treated for prostate cancer. This study describes the effect of prior prostate cancer treatment on perioperative and pathological outcomes after cystectomy. METHODS: This was a retrospective review of all male patients who underwent cystectomy at our institution from 01/01/2007-01/01/2020. Patients who were previously diagnosed and treated for prostate cancer were identified and outcomes were assessed. RESULTS: In 525 male patients, 132 (25.1%) had a diagnosis of prostate cancer prior to cystectomy. In the patients with a history of prostate cancer, 59 (46.2%) patients underwent prior radical prostatectomy (RP), 52 (39.4%) underwent some form of radiation therapy and the remaining 21 were managed with other modalities, including 11.4% who were on active surveillance. When comparing perioperative outcomes, there were no significant differences in outcomes, though a rectal injury appeared to be more common in patients who previously underwent a RP (5.1%, p=0.303). Pathological outcomes revealed that pT4 disease was more common in the RT cohort (19.2%, p=0.05). Median lymph node count was highest in the group with no prior history of prostate cancer and those who were previously on active surveillance (p <0001). In patients with no history of prostate cancer, 151 (40.2%) were found to have incidental prostate cancer at the time of cystectomy. Most (67.5%) patients with incidental prostate cancer had Gleason <7 disease and only 1.3% developed metastatic prostate cancer on follow-up, compared to over 10% of the patients previously treated for prostate cancer (p <0.05). CONCLUSIONS: Patients who underwent prostate cancer treatment prior to cystectomy may be at increased risk for worse perioperative and pathologic outcomes after cystectomy. Therefore, these patients require special perioperative considerations such as referrals to experienced cystectomy centers and/or medical oncology referral for assessment for appropriateness of neoadjuvant/adjuvant systemic therapies in those who have advanced bladder cancer. Source of Funding: This study was supported by Grant Number P30 CA015083 from the National Cancer Institute (NCI). Its contents are solely the responsibility of the authors and do not necessarily represent the official view of the NIH. © 2021 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 206Issue Supplement 3September 2021Page: e1059-e1059 Advertisement Copyright & Permissions© 2021 by American Urological Association Education and Research, Inc.MetricsAuthor Information Kassem Faraj More articles by this author Weslyn Bunn More articles by this author Victoria Edmonds More articles by this author Mark Tyson More articles by this author Expand All Advertisement Loading ...
Read full abstract